Indefinite Delivery Contract SPE2DR25D9210

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The original solicitation, titled "Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)", aims to establish Prime Vendor Contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. The procurement is unrestricted and fully competitive, with the intent to diversify the pharmaceutical supply chain and increase the Department of Defense's resiliency during contingencies or natural disasters.